Abstract
Respiratory viruses continue to afflict mankind. Among them, pathogens such as coronaviruses [including the current pandemic agent known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] and the one causing influenza A (IAV) are highly contagious and deadly. These can evade the immune system defenses while causing a hyperinflammatory response that can damage different tissues/organs. Simultaneously targeting several immunomodulatory proteins is a plausible antiviral strategy since it could lead to the discovery of indirect-acting pan-antiviral (IAPA) agents for the treatment of diseases caused by respiratory viruses. In this context, computational approaches, which are an essential part of the modern drug discovery campaigns, could accelerate the identification of multi-target immunomodulators. This perspective discusses the usefulness of computational multi-target drug discovery for the virtual screening (drug repurposing) of IAPA agents capable of boosting the immune system through the activation of the toll-like receptor 7 (TLR7) and/or the stimulator of interferon genes (STING) while inhibiting key inflammation-related proteins such as caspase-1 and tumor necrosis factor-alpha (TNF-α).
Keywords: Antiviral, Caspase-1, Coronaviruses, Indirect-acting pan-antiviral, Influenza, Multi-target, PTML, STING, TLR7, TNF-α.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:Indirect-Acting Pan-Antivirals vs. Respiratory Viruses: A Fresh Perspective on Computational Multi-Target Drug Discovery
Volume: 21 Issue: 30
Author(s): Valeria V. Kleandrova, Marcus T. Scotti and Alejandro Speck-Planche*
Affiliation:
- Postgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Paraíba, 58051-900, João Pessoa,Brazil
Keywords: Antiviral, Caspase-1, Coronaviruses, Indirect-acting pan-antiviral, Influenza, Multi-target, PTML, STING, TLR7, TNF-α.
Abstract: Respiratory viruses continue to afflict mankind. Among them, pathogens such as coronaviruses [including the current pandemic agent known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] and the one causing influenza A (IAV) are highly contagious and deadly. These can evade the immune system defenses while causing a hyperinflammatory response that can damage different tissues/organs. Simultaneously targeting several immunomodulatory proteins is a plausible antiviral strategy since it could lead to the discovery of indirect-acting pan-antiviral (IAPA) agents for the treatment of diseases caused by respiratory viruses. In this context, computational approaches, which are an essential part of the modern drug discovery campaigns, could accelerate the identification of multi-target immunomodulators. This perspective discusses the usefulness of computational multi-target drug discovery for the virtual screening (drug repurposing) of IAPA agents capable of boosting the immune system through the activation of the toll-like receptor 7 (TLR7) and/or the stimulator of interferon genes (STING) while inhibiting key inflammation-related proteins such as caspase-1 and tumor necrosis factor-alpha (TNF-α).
Export Options
About this article
Cite this article as:
Kleandrova V. Valeria , Scotti T. Marcus and Speck-Planche Alejandro *, Indirect-Acting Pan-Antivirals vs. Respiratory Viruses: A Fresh Perspective on Computational Multi-Target Drug Discovery, Current Topics in Medicinal Chemistry 2021; 21 (30) . https://dx.doi.org/10.2174/1568026621666211012110819
DOI https://dx.doi.org/10.2174/1568026621666211012110819 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Chronic Diarrhea and AIDS: Insights into Studies with Non-Human Primates
Current HIV Research Protein Targeting Constructs in Alpha Therapy
Current Radiopharmaceuticals The Use of Intermittent Non-Invasive Ventilation as an Alveolar Recruitment Method for Patient with Severe COVID-19 Pneumonia
New Emirates Medical Journal Effectiveness of Antiviral and Immunomodulatory Agents in the Treatment of COVID-19: A Systematic Review
Current Respiratory Medicine Reviews Antiviral Activity of Natural and Synthetic Brassinosteroids
Current Medicinal Chemistry - Anti-Infective Agents New Analogues of Mycophenolic Acid
Mini-Reviews in Medicinal Chemistry Major Drugs Used in COVID-19 Treatment: Molecular Mechanisms, Validation and Current Progress in Trials
Coronaviruses Most Promising Compounds for Treating COVID-19 and Recent Trends in Antimicrobial & Antifungal Agents
Current Topics in Medicinal Chemistry Binding Mechanism of H5N1 Influenza Virus Neuraminidase with Ligands and its Implication for Drug Design
Medicinal Chemistry Mass Spectrometry, Proteomics, Data Mining Strategies and Their Applications in Infectious Disease Research.
Anti-Infective Agents in Medicinal Chemistry Glycyrrhizin as a Potential Treatment for the Novel Coronavirus (COVID-19)
Mini-Reviews in Medicinal Chemistry A Case Study: Analysis of Patents on Coronaviruses and Covid-19 for Technological Assessment and Future Research
Current Pharmaceutical Design Viral Evolution will Automatically Resolve COVID-19 Pandemic
Combinatorial Chemistry & High Throughput Screening Natural Products, a Potential Therapeutic Modality in Management and Treatment of nCoV-19 Infection: Preclinical and Clinical Based Evidence
Current Pharmaceutical Design Novel Coronavirus SARS-CoV-2 (COVID-19) and Pregnancy: A Hypothetical View
Endocrine, Metabolic & Immune Disorders - Drug Targets Utilizing Zebrafish Animal Model as a Helping Hand for COVID-19 Infection
Coronaviruses Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review
CNS & Neurological Disorders - Drug Targets Activity of Some Novel Chalcone Substituted 9-anilinoacridines against Coronavirus (COVID-19): A Computational Approach
Coronaviruses Comparison of General Dietary and Lifestyle Habits Before and During COVID-19 among the Saudi Adult Population in Riyadh
Current Nutrition & Food Science Molecular Docking Studies of Bioactive Nicotiflorin against 6W63 Novel Coronavirus 2019 (COVID-19)
Combinatorial Chemistry & High Throughput Screening